Childhood anxiety, even severe and chronic, doesn’t necessarily stand in the way of success and achievement. But caring parents will do anything to help relieve their children of misery. Scott Stossel, the editor of The Atlantic magazine, tells his story of struggling, coping, and living a very productive life.Read
It started at the onset of puberty, when I was 11 years old. I was at school, watching my older sister load the school bus to be taken away to 6th-grade camp. Suddenly a wave of panic overcame me. I don't recall my physical symptoms other than a racing heart and nausea.Read
Instead of letting her depression run her life, she decided to outrun it.
“I have clinical depression,” says Mara Suttman-Lea. “No, I am not depressed. I suffer from depression. They are two vastly different concepts.”
An expert explains why reassuring words that you won't get Ebola are often not enough to soothe your anxieties.
Take an anonymous online screening or locate a mental health screening site, including those for college students and military and their families. Screening for depression is as important as screening for physical diseases because early identification makes treatment more effective.
ADAA mourns the loss of Robin Williams and too many others whose lives have ended due to suicide. His tragic death illustrates the great need for increased public awareness of the grave risk that suicide poses.
The purpose of this study is to learn which of two forms of therapy is more likely to help people who have body dysmorphic disorder (BDD). We are comparing cognitive-behavioral therapy (CBT), which is a promising new treatment for BDD, and supportive psychotherapy (SPT), which appears to be the most widely used therapy in the community to treat BDD and related problems, such as low self-esteem or problems with family members or friends.
Adults (age18 or older):
Research shows that people with PTSD are more likely to smoke than people without PTSD. It also shows that people with PTSD have more difficulty at attempts to quit smoking. This study is part of a program aimed at finding out how best to help smokers quit who also have PTSD.
The purpose of the current study is to evaluate the efficacy of d-cycloserine in augmenting treatment of smoking cessation for individuals with panic attacks. Individuals will receive 7 weeks of panic- and smoking-reduction treatment (PSRT) and one pill of d-cycloserine (DCS) or one pill placebo one hour prior to sessions 3, 4, and 5 (i.e., 3 single doses). Participants will also be given nicotine replacement therapy as part of PSRT (i.e., the patch).